Yara International ASA (NASDAQ: YARIY), Meridian Bioscience, Inc. (NASDAQ: VIVO), Zurich Financial Services (NASDAQ: ZFSVY), Aon Co. (NYSE: AON), Bancolombia S.A. (NYSE: CIB) and Aixtron AG (NASDAQ: AIXG) ratings and price targets.
Meridian Bioscience, Inc. (VIVO) was downgraded by Wedbush from a “Neutral” rating to an “Underperform” rating.
Yara International ASA (YARIY) was downgraded by Credit Suisse (NYSE:CS) from an “Outperform” rating to a “Neutral” rating.
Zurich Financial Services (ZFSVY) was downgraded by JPMorgan Chase & Co. (NYSE:JPM) from an “Overweight” rating to a “Neutral” rating.
Aon Co. ( AON) was upgraded by Credit Suisse (NYSE:CS) from an “Underperform” rating to a “Neutral” rating. They have a price target of $50.00 on the company.
Bancolombia S.A. (CIB) was upgraded by Raymond James (NYSE:RJF) to an “Outperform” rating.
BNP Paribas initiated coverage on Aixtron AG (AIXG). They placed an “Underperform” rating on the company.
Showing posts with label Meridian Bioscience. Show all posts
Showing posts with label Meridian Bioscience. Show all posts
Wednesday, February 1, 2012
Tuesday, May 10, 2011
Coverage on (TRGP) (VIVO) (VRX) (VVC) Initiated
Coverage on Targa Resources Investments Inc (NASDAQ: TRGP), Meridian Bioscience, Inc. (NASDAQ: VIVO), Valeant Pharmaceuticals (NYSE: VRX) and Vectren Corporation (NYSE: VVC) initiated by analysts.
Credit Suisse (NYSE:CS) initiated coverage on Targa Resources Investments Inc (TRGP). They placed a “neutral” rating on the company.
Sidoti initiated coverage on Meridian Bioscience, Inc. (VIVO). They placed a “neutral” rating and a price target of $25.00 on the company.
Goldman Sachs (NYSE:GS) initiated coverage on Valeant Pharmaceuticals (VRX). They placed a “neutral” rating and a price target of $50.00 on the company.
Wells Fargo & Co. (NYSE:WFC) initiated coverage on Vectren Corporation (VVC). They placed a “market perform” rating on the company.
Credit Suisse (NYSE:CS) initiated coverage on Targa Resources Investments Inc (TRGP). They placed a “neutral” rating on the company.
Sidoti initiated coverage on Meridian Bioscience, Inc. (VIVO). They placed a “neutral” rating and a price target of $25.00 on the company.
Goldman Sachs (NYSE:GS) initiated coverage on Valeant Pharmaceuticals (VRX). They placed a “neutral” rating and a price target of $50.00 on the company.
Wells Fargo & Co. (NYSE:WFC) initiated coverage on Vectren Corporation (VVC). They placed a “market perform” rating on the company.
Labels:
Credit Suisse,
Goldman Sachs,
Meridian Bioscience,
Targa Resources,
Valeant Pharmaceuticals,
Vectren Corp,
Wells Fargo
Subscribe to:
Posts (Atom)